ARTICLE | Financial News
Provention raises $64M IPO
July 20, 2018 12:15 AM UTC
Autoimmune and infectious disease company Provention Bio Inc. (NASDAQ:PRVB) raised $63.9 million on Thursday through the sale of 16 million shares at $4 in an IPO underwritten by MDB Capital Group and Dougherty & Co. The offering was conducted on a best efforts basis.
The offering values the company at $149.4 million. ...
BCIQ Company Profiles